Gujarat Terce Laboratories Limited

GUJTERC6

INE499G01013

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:01:00 2024-07-18 EDT			5-day change	1st Jan Change
48.37 ^INR	-4.99%		+4.63%	+69.78%

07-01	Gujarat Terce Laboratories Limited announced that it has received INR 3.496675 million in funding	CI
05-29	Gujarat Terce Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Gujarat Terce Laboratories Limited Announces Resignation of Dilipkumar Nikhare from the Post of Company Secretary

January 08, 2020 at 08:19 am

Gujarat Terce Laboratories Limited announced the resignation of Mr. Dilipkumar Nikhare from the post of company secretary and compliance officer has resigned due to personal reasons with effect from January 8, 2020.

Latest news about Gujarat Terce Laboratories Limited

Gujarat Terce Laboratories Limited announced that it has received INR 3.496675 million in funding	06-30	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-29	CI
Gujarat Terce Laboratories Limited announced that it expects to receive INR 3.496675 million in funding	03-28	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-05	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-13	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-13	CI
Gujarat Terce Laboratories Limited Approves Appointment of Ripal Sachinkumar Sukhadiya as the Company Secretary & Compliance Officer	23-03-07	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-31	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-31	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Gujarat Terce Laboratories Limited Announces Resignation of Ashka Solanki as Company Secretary and Compliance Officer	22-09-06	CI
Gujarat Terce Laboratories Limited Approves the Appointment of Natwarbhai Prajapati as the Whole Time Director	22-08-24	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-05	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-30	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-01-24	CI
Gujarat Terce Laboratories Appoints New CEO	21-10-28	MT
Gujarat Terce Laboratories CEO Resigns	21-10-28	MT
Gujarat Terce Laboratories Limited Announces Resignation of Natwarbhai Prajapati as Managing Director	21-10-28	CI
Gujarat Terce Laboratories Limited Announces Executive Changes	21-10-28	CI
Gujarat Terce Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-10-28	CI
Gujarat Terce Laboratories : Turns to Profit in Fiscal Q1	21-07-23	MT
Gujarat Terce Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-23	CI

Chart Gujarat Terce Laboratories Limited

Duration

Period

Chart Gujarat Terce Laboratories Limited

More charts

Company Profile

Gujarat Terce Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its diverse portfolio encompasses approximately 70 brands and 180 stock-keeping units (SKUs) covering multiple dosage forms, such as tablets, capsules, oral liquids, ointments and injectables. The Company offers therapies in areas of antibiotics, gynecology, respiratory, nutraceuticals, gastrointestinal and anti-fungal. The Companyâs brands include Acolate, Codimol, Resplash, Terflora Z, Thyter, Tynol, Z-Oxi, and Vitfol. The Company has approximately eight brands occupying a space in the top 10 in various therapeutic areas. The Company has a presence in over 13 states in India. The Company also has a presence in Eastern and Western Africa, the association of Southeast Asian Nations (ASEAN), and Latin American (LATAM) countries.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GUJARAT TERCE LABORATORIES LIMITED	+69.78%	4.52M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+26.58%	45.33B
OTSUKA HOLDINGS CO., LTD.	+38.49%	25.36B
SANDOZ GROUP AG	+27.75%	16.7B
CIPLA LIMITED	+20.89%	14.59B
ZYDUS LIFESCIENCES LIMITED	+72.03%	14.26B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-10.35%	6.67B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.07%	5.62B
STADA ARZNEIMITTEL	-8.87%	5.73B